1887

Abstract

Clinical isolates of spp. were examined for their susceptibility to human serum. The susceptibility of the strains to immune and nonimmune human serum was dependent upon the size of the bacterial inoculum and the concentration of serum. There were differences among spp. in susceptibility to human serum: strains were the least susceptible, strains of and serotype 6 were intermediate, and those of other than serotype 6 and were the most susceptible. Experiments in which heat-treated (56 °C for 30 min, or 50 °C for 20 min) serum was used, and analysis of activation of complement by lipopolysaccharides (LPS) from each sp., suggested that LPS composition, especially the O antigen polysaccharide chains, contributes to the differences among spp. in susceptibility to human serum.

Loading

Article metrics loading...

/content/journal/micro/10.1099/00221287-134-7-2057
1988-07-01
2024-12-03
Loading full text...

Full text loading...

/deliver/fulltext/micro/134/7/mic-134-7-2057.html?itemId=/content/journal/micro/10.1099/00221287-134-7-2057&mimeType=html&fmt=ahah

References

  1. Blaser M. J., Pollard R. A., Feldman R. A. 1983; Shigella infections in the United States, 1974-1980. Journal of Infectious Diseases 147:771–775
    [Google Scholar]
  2. Blaser M. J., Smith P. F., Kohler P. F. 1985; Susceptibility of Campylobacter isolates to the bactericidal activity of human serum. Journal of Infectious Diseases 151:227–235
    [Google Scholar]
  3. Dupont H. L., Pickering L. K. 1980 Infections of the Gastrointestinal Tract. Microbiology, Pathophysiology, and Clinical Features New York: Plenum;
    [Google Scholar]
  4. Fine D. P., Marney S. M. Jr Colley D. G., Sergent J. S., Desprez R. M. 1972; C3 shunt activation in human serum chelated with EGTA. Journal of Immunology 109:807–809
    [Google Scholar]
  5. Gotze O., Muller-Eberhard H. J. 1971; The C3-activator system: an alternative pathway of complement activation. Journal of Experimental Medicine 134: (supplement) 90–108
    [Google Scholar]
  6. Hallet A. F., Scragg J. N. 1978; Shigella bacteraemia in Africans. Transactions of the Royal Society of Tropical Medicine and Hygiene 72:673–674
    [Google Scholar]
  7. Joiner A., Hammerc C. H., Browne E. J., Cole R. J., Frank M. M. 1982; Studies on the mechanism of bacterial resistance to complementmediated killing. I. Terminal complement components are deposited and released from Salmonellaminnesota S218 without causing bacterial death. Journal of Experimental Medicine 155:797–808
    [Google Scholar]
  8. Keusch G. T. 1979; Shigella infections. Clinics in Gastroenterology 8:645–662
    [Google Scholar]
  9. Koshi G., Daniel J., Pereira S. M. 1979; Septicaemic manifestations of shigellosis. Indian Journal of Medical Research 70:916–922
    [Google Scholar]
  10. Labrec E. H., Schneider H., Magnani T. J., Formal S. B. 1964; Epithelial cell penetration as an essential step in the pathogenesis of bacillary dysentery. Journal of Bacteriology 88:1503–1518
    [Google Scholar]
  11. Lindberg B. 1979; Structural studies on lipopolysac- charide. In Microbiology -1979 pp. 172–175 Schlessinger D. Edited by Washington, DC: American Society for Microbiology;
    [Google Scholar]
  12. Lowell G., Macdermott R., Summers P., Reeder A., Bertovich M., Formal S. B. 1980; Antibody-dependent cell-mediated antibacterial activity : K lymphocytes, monocytes, and granulocytes are effective against Shigella. Journal of Immunology 125:2778–2784
    [Google Scholar]
  13. Martin T. B., Habbick F., Nyssen J. 1983; Shigellosis with bacteremia: a report of two cases and a review of the literature. Pediatric Infectious Disease 2:21–26
    [Google Scholar]
  14. Mayer M. M. 1961; Complement and complement fixation. In Experimental Immunochemistry pp. 133–240 Kabat E. A., Mayer M. M. Edited by Springfield: Charles C. Thomas;
    [Google Scholar]
  15. Moll A., Cabello F., Timmis K. 1979; Rapid assay for the determination of bacterial resistance to the lethal activity of serum. FEMS Microbiology Letters 6:273–276
    [Google Scholar]
  16. Morgan D. R., Dupont H. L., Gonik B., Kohl S. 1984 a; Cytotoxicity of human peripheral blood and colostral leukocytes against Shigella species. Infection and Immunity 46:25–33
    [Google Scholar]
  17. Morgan D. R., Dupont H. L., Wood L. V., Kohl S. 1984b; Cytotoxicity of leukocytes from normal and S/nge//a-susceptible (opium-treated) guinea pigs against virulent Shigella sonnei. Infection and Immunity 46:22–24
    [Google Scholar]
  18. Odumeru J. A., Wiseman G. M., Ronald A. R. 1985; Role of lipopolysaccharide and complement in susceptibility of Haemophilus ducreyi to human serum. Infection and Immunity 50:495–499
    [Google Scholar]
  19. Ogawa H., Nakamura A., Nakaya R., Mise K., Honjo S., Takasaka M., Fujiwara T., Imai-ZUMI K. 1967; Virulence and epithelial cell invasiveness of dysentery bacilli. Japanese Journal of Medical Science and Biology 20:315–328
    [Google Scholar]
  20. Okamura N., Nagai T., Nakaya R., Kondo S., Murakami M., Hisatsune K. 1983; HeLa cell invasiveness and O antigen of Shigella flexneri as separate and prerequisite attributes of virulence to evoke keratoconjunctivitis in guinea pigs. Infection and Immunity 39:505–513
    [Google Scholar]
  21. Parker M. T. 1984; Bacillary dysentery. In Topley and Wilson's Principles of Bacteriology, Virology and Immunity 3 Bacterial Diseases,pp. 434–445 Wilson G. S., Miles A. A., Parker M. T. Edited by London: Edward Arnold;
    [Google Scholar]
  22. Quinn P. H., Crosson F. J. Jr Winkelstein A., Moaxon E. R. 1977; Activation of the alternative complement pathway by Haemophilus influenzae type b. Infection and Immunity 16:400–402
    [Google Scholar]
  23. Reed W. P. 1975; Serum factors capable of opsonizing Shigella for phagocytosis by polymorphonuclear neutrophils. Immunology 28:1051–1059
    [Google Scholar]
  24. Reed W. P., Albright E. L. 1974; Serum factors responsible for killing of Shigella. Immunology 26:205–215
    [Google Scholar]
  25. Schiller N. L., Alazard M. J., Borowski R. S. 1984; Serum sensitivity of a Pseudomonas aerugin Osa mucoid strain. Infection and Immunity 45:748–755
    [Google Scholar]
  26. Schoolnik G. K., Buchanan T. M., Holmes K. K. 1976; Gonococci causing disseminated infection are resistant to the bactericidal action of normal serum. Journal of Clinical Investigation 58:1163–1173
    [Google Scholar]
  27. Schwab G. E., Reeves P. R. 1966; Comparison of the bactericidal activity of different vertebrate sera. Journal of Bacteriology 91:106–112
    [Google Scholar]
  28. Shafer W. M., Joiner K., Guymon F., Cohen M. S., Sparling P. F. 1984; Serum sensitivity of Neisseria gonorrhoeae : the role of lipopolysaccharide. Journal of Infectious Diseases 149:175–183
    [Google Scholar]
  29. Skarnes R. C. 1978; Humoral bactericidal systems: nonspecific and specific mechanisms. Infection and Immunity 19:515–522
    [Google Scholar]
  30. Stoll B.J, Glass R. I., Huq M. I., Khan M., Banu H., Holt J. 1982; Epidemiologic and clinical features of patients infected with Shigella who attended a diarrheal disease hospital in Bangladesh. Journal of Infectious Diseases 146:177–183
    [Google Scholar]
  31. Struelens M. J., Patte D., Kabir I., Salam A., Nath S. K., Butler T. 1985; Shigella septicemia: prevalence, presentation, risk factors, and outcome. Journal of Infectious Diseases 152:784–790
    [Google Scholar]
  32. Taylor P. W. 1983; Bactericidal and bacteriolytic activity of serum against gram-negative bacteria. Microbiological Reviews 47:46–83
    [Google Scholar]
  33. Taylor P. W., Parton R. 1977; A protein factor associated with serum resistance in Escherichia coli. Journal of Medical Microbiology 10:225–232
    [Google Scholar]
  34. Wardlaw A. C., Pillemer L. 1956; The properdin system and immunity. V. The bactericidal activity of the properdin system. Journal of Experimental Medicine 103:553–575
    [Google Scholar]
  35. Westphal O., Lüderitz O., Bister R. 1952; liber die Extraktion von Bakterien mit Phenol/ Wasser. Zeitschrift Jur Naturforschung 7b:148–155
    [Google Scholar]
/content/journal/micro/10.1099/00221287-134-7-2057
Loading
/content/journal/micro/10.1099/00221287-134-7-2057
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error